Xellia Pharmaceuticals Competitors and Similar CompaniesClear all

Xellia Pharmaceuticals's competitors and similar companies include Cipla.
Xellia Pharmaceuticals
Xellia Pharmaceuticals
Xellia Pharmaceuticals is a company focused on providing anti-infective treatments against life-threatening infections.
Cipla
Cipla
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date
Founding Date
1903
Founding Date
1935
Type
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Copenhagen, DK HQ
Shanghai, CN
Taizhou, CN
Zagreb, HR
Budapest, HU
Bengaluru, IN
Oslo, NO
see more
Locations
Mumbai, IN HQ
Melbourne, AU
Antwerpen, BE
São Paulo, BR
São Paulo, BR
Unterhaching, DE
Nairobi, KE
see more
Employees
Employees
45317% decrease
Employees
27,764

Financial

Revenue (est.)
Revenue (est.)
kr1.5b (FY, 2025)
Revenue (est.)
₹277.1b (FY, 2026)
Cost of goods
Cost of goods
kr1.1b (FY, 2025)
Cost of goods
₹97.2b (FY, 2026)
Gross profit
Gross profit
kr314.9m (FY, 2025)
Gross profit
₹184.4b (FY, 2026)
Net income
Net income
kr213.7m (FY, 2025)
Net income
₹38.7b (FY, 2026)
For sources of this data, please see the company profile

View Company Profiles

Cipla
HQ
Mumbai, IN
Employees
27,764

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.

View company